Read + Share
Amedeo Smart
Independent Medical Education
Teng HW. In Reply: Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal Cancer. Am J Clin Oncol 2020;43:905-906.PMID: 33492838
Email
LinkedIn
Facebook
Twitter
Privacy Policy